Skip to content

Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma

Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04846192
Enrollment
40
Registered
2021-04-15
Start date
2021-04-30
Completion date
2021-05-31
Last updated
2021-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perihilar Cholangiocarcinoma

Keywords

sarcopenia, nutritional status, surgery

Brief summary

Curative treatment of peri hilar cholangiocarcinomas is R0 surgery and require major hepatectomy with biliary tract resection. These complexe procedures can lead to high morbidity and mortality. A severe alteration of nutritional status before the surgery might be a poor prognosis for survival.

Detailed description

Peri hilar cholangiocarcinomas are rare tumors, which when diagnosed at the resectable stage, require major hepatic resection associated with biliary reconstruction. These are complex procedures with a high morbidity and mortality, mainly due to postoperative hepatic failure and sepsis. These patients undergo optimization of liver function with portal embolization according to the volume of the future remaining liver and preoperative biliary drainage. On top of technical challenges of the surgery, the patients usually present a significant alteration of the general condition at the time of diagnosis, with denutrition that can be severe. The importance of evaluating the preoperative nutritional status in the context of oncological surgery is increasingly recognized in the literature. Different nutritional scores exist such as the CONUT score, PNI, or the evaluation of sarcopenia on imaging examinations and have shown an impact on morbi-mortality in liver surgery.

Interventions

Collecting existing data on pre operative nutritional status and outcomes after surgery

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Surgical peri hilar cholangiocarcinoma from 01/01/2003 to 04/01/2021 at Nancy University Hospital

Exclusion criteria

* Non curative surgery

Design outcomes

Primary

MeasureTime frame
Overall Survival01/01/2003 to 04/01/2021
Disease Free Survival01/01/2003 to 04/01/2021

Secondary

MeasureTime frameDescription
Morbidity01/01/2003 to 04/01/2021Post operative complications : Dindo-Clavien \> or = 3

Countries

France

Contacts

Primary ContactJulie Leclerc, MD
j.leclerc@chru-nancy.fr0383154207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026